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Abstract The aim of this study was to identify patients with
methicillin-resistant Staphylococcus aureus (MRSA) bacter-
emia with low risk of infective endocarditis (IE) who might
not require routine trans-esophageal echocardiography (TEE).
We retrospectively evaluated 398 patients presenting with
MRSA bacteremia for the presence of the following clinical
criteria: intravenous drug abuse (IVDA), long-term catheter,
prolonged bacteremia, intra-cardiac device, prosthetic valve,
hemodialysis dependency, vertebral/nonvertebral osteomyeli-
tis, cardio-structural abnormality. IE was diagnosed using the
modified Duke criteria. Of 398 patients with MRSA bacter-
emia, 26.4% of cases were community-acquired, 56.3%were
health-care-associated, and 17.3 % were hospital-acquired. Of
the group, 44 patients had definite IE, 119 had possible IE, and
235 had a rejected diagnosis. Out of 398 patients, 231 were
evaluated with transthoracic echocardiography (TTE) or TEE.
All 44 patients with definite IE fulfilled at least one criterion
(sensitivity 100 %). Finally, a receiver operator characteristic
(ROC) curve was obtained to evaluate the total risk score of
our proposed criteria as a predictor of the presence of IE, and
this was compared to the ROC curve of a previously proposed
criteria. The area under the ROC curve for our criteria was
0.710, while the area under the ROC curve for the criteria
previously proposed was 0.537 (p<0.001). The p-value for
comparing those 2 areas was less than 0.001, indicating sta-
tistical significance. Patients with MRSA bacteremia without
any of our proposed clinical criteria have very low risk of
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Staphylococcus aureus bacteremia (SAB) is a leading cause
of mortality and morbidity in both nosocomial and com-
munity settings [1–5]. It is the second most common
cause of hospital bloodstream infections, and has become
the leading cause of infective endocarditis (IE) in most
parts of the world [6–11]. Despite recent advances in
diagnosis and treatment, IE remains a serious and deadly
disease [8, 12–16]. Its 30-day all-cause mortality remains
as high as 23.9 % in left-sided IE and 11.8 % in right-
sided IE [17, 18]. The classic peripheral stigmata of IE
are often nonspecific or missing, particularly among pa-
tients in whom IE is the result of Staphylococcus aureus
infection [19, 20]. The high mortality of untreated IE,
accompanied by a high prevalence of patients without
clinical manifestations [8], emphasizes the importance
of a diagnostic strategy sensitive enough for disease de-
tection [21, 22]. The current European Society of Cardi-
ology, the American College of Cardiology/American
Heart Association guidelines for IE, and other recent
studies recommend performing routine transthoracic
echocardiography (TTE) in all patients with suspected
IE [19, 23–25]. Furthermore, cost-effective calculations
suggest that transesophageal echocardiography (TEE)
should be done first in adults with suspected IE [19]. It
has also been suggested that all patients with SAB
should be considered as high risk for developing IE,
and they should all undergo TTE/TEE evaluation [23,
24, 26]. Habib et al. suggested that a negative TTE in
patients with SAB should be followed by TEE, due to
the high clinical suspicion of IE in patients with SAB
[27]. Whether all patients with SAB need a TEE is an
unsettled issue. Recent literature suggests that further
work is needed to identify a subgroup of patients with
SAB that might only need TTE for their evaluations of
IE [19]. It has been proposed that the absence of certain
clinical characteristics can identify patients with SAB
with low risk of IE that might not require TEE evalua-
tion [1, 28]. As such, the aim of our study was to iden-
tify patients with SAB with low risk of IE by using
simplified prediction criteria that include common risk
factors for IE.
Methods
Hospital patients and settings
We retrospectively identified all consecutive patients with
methicillin-resistant Staphylococcus aureus (MRSA) bacter-
emia diagnosed at a large tertiary care center, Henry Ford
Hospital in Detroit, Michigan from 2005 to 2009. Cases of
MRSA bacteremia were identified from review of the records
of the clinical microbiology laboratory. All patients ≥18 years
old with community-acquired, health-care-associated, or nos-
ocomial MRSAwho had ≥1 blood culture positive for MRSA
were included in the study. The Henry Ford Hospital Institu-
tional Review Board approved the study protocol.
Data acquisition
Patients with MRSA bacteremia were evaluated for date, du-
ration, epidemiologic source and number of positive blood
cultures, source of infection, clinical signs of IE, presence of
vascular events (emboli, hemorrhage), hemodialysis depen-
dency, short-term catheter, implantable catheter, fistula or
graft, diabetes, vertebral or non-vertebral osteomyelitis, pros-
thetic heart valve, intravenous drug use (IVDU), intra-cardiac
device, cardio-structural abnormality, new conduction block,
infective endocarditis diagnosis, type and timing of ultrasound
studies, specialty of physician ordering the ultrasound.
Definitions
MRSA bacteremia was defined as ≥1 positive blood culture,
and it was considered (1) hospital-acquired if the blood cul-
ture was positive ≥48 h after admission and infection was not
present or incubating at time of admission, (2) health-care-
associated if infection was outpatient or within the first 48 h
of hospitalization and the patient was hospitalized within the
previous year, or (3) community-acquired if infection was
outpatient or within the first 48 h of hospitalization and the
patient was not hospitalized within the previous year [29]. The
source of bacteremia was defined as the most likely source
responsible for the first possible blood culture result on the
basis of clinical signs, imaging, and microbiological findings.
Prolonged bacteremia was considered Bdocumented^ if
follow-up blood cultures yielded MRSA 2–4 days (at least
12 h after initial blood culture) after the first positive blood
culture result. We selected this definition of prolonged bacter-
emia with the goal of making our criteria more sensitive to
detect patients with lower risk of IE. If a patient did not have a
follow-up blood culture, they were considered in the group of
Bpossible^ prolonged bacteremia. In our analysis, Bpossible^
and Bdocumented^ bacteremia were considered as prolonged
bacteremia.
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Short-term catheter was defined as any peripherally
inserted central catheter (PICC), internal jugular vein catheter,
subclavian vein catheter, radial arterial catheter, or femoral
arterial catheter or arterial line. Implantable catheter was de-
fined as any tunneled catheter or mediport. Intra-cardiac de-
vice was defined as any implantable cardioverter–defibrillator
(ICD) or permanent pacemaker (PPM). Previous IE was de-
fined as any prior episode of IE, whether related or not related
to an infected intra-cardiac device. IE was defined as definite
based on modified Duke criteria [30]. IE was excluded based
on modified Duke criteria [30].
Criteria set
The criteria set was devised based on previous studies that
have identified significant IE risk factors in a proposed clinical
criteria including: prolonged bacteremia [31, 32], permanent
intra-cardiac device (e.g., a prosthetic heart valve, pacemaker,
or cardioverter–defibrillator) [33, 34], hemodialysis depen-
dency [35], spinal infection (e.g., vertebral osteomyelitis, epi-
dural, subdural or intra-spinal empyema, or abscess) and non-
vertebral osteomyelitis [1, 36, 37]. This criteria set was found
to have a sensitivity of 97.5–100 % and a negative predictive
value of 92.2–100 % [1]. One of its limitations is its applica-
bility to other populations with different risk factor profiles.
Other studies have also included risk factors such as intrave-
nous drug use [24, 38], known native valve abnormality [24,
38], previous IE [24, 38], and presence of central venous ac-
cess [38–40]. Taking into consideration these previously pro-
posed risk factors and our population profile, we developed
our modified criteria for predicting IE, including prolonged
bacteremia, intravenous drug use, implantable catheter, intra-
cardiac device, prosthetic valve, hemodialysis, osteomyelitis,
previous infective endocarditis, and cardio-structural
abnormality.
Echocardiography data: all echocardiograms (TTE and
TEE) were performed by the American Society of Echocardi-
ography Level 2 and 3 trained echocardiographers. A vegeta-
tion was defined as a definite oscillating mass, irregular in
character, located on the atrial surface of the mitral and tricus-
pid valves or ventricular surface of the aortic or pulmonic
valves. If there was suspicion of vegetation, abnormal leaflet
thickening, abscess, or worsening of valvular regurgitation
noted on TTE, a TEE was recommended as a follow-up study.
If image quality on TTE was not sufficient to assess valves
and mural endocardium, a TEE was also recommended for
further evaluation.
Data analysis
The individual risk variables have been scored as 0 (no) or 1
(yes) and added together to create a total risk score. Then a
cross-tabulation table was used to display the association of
the total risk score with endocarditis status, with the Cochran–
Armitage trend test used to evaluate the strength of that asso-
ciation. Furthermore, to evaluate the total risk score as a pre-
dictor of the presence of endocarditis, a receiver operating
characteristic (ROC) curve was created, and the resulting area
under the ROC curve was calculated. The optimal cut point
from the total risk score was defined as the one containing the
maximum sum of the sensitivity plus specificity for predicting
endocarditis. Finally, logistic regression modeling was used to
evaluate the multivariable association of endocarditis status
with the individual risk variables and patient characteristics.
Results
A total of 398 patients with MRSA bacteremia were identified
and included in the analysis. Of these, 59.8 % were male, and
the mean age was 58.6 ± 17.1 years: 105 (26.4 %) were com-
munity-acquired, 224 (56.3 %) were health-care-associated
and 69 (17.3 %) were hospital-acquired. The median duration
of theMRSA bacteremia was 4 (2 to 6) days. Of the patients in
our cohort, 161 (40.5 %) had diabetes, 90 (22.6 %) were
hemodialysis-dependent, 20 (5 %) had human immunodefi-
ciency virus, 85 (21.3 %) were IVDU, and 19 (4.7 %) had a
prosthetic valve. The demographic and other clinical features
of the cohort are displayed in Table 1.
Diagnosis of infective endocarditis
The diagnosis of IE was classified as definite in 44 [11], pos-
sible in 119 (29.9 %) and rejected in 235 (59 %) based on
modified Duke criteria. Of these, 14 (3.5 %) patients had
tricuspid valve vegetation, 12 (3 %) mitral valve vegetation,
and eight (2 %) aortic valve vegetation. Of the total 398 pa-
tients, 241 (60.5 %) were evaluated with echocardiography
(TTE or TEE). Of the 157 patients not evaluated with echo-
cardiography, 116 (73.8 %) were categorized as rejected in-
fective endocarditis, based on the modified Duke criteria, nine
(5.7 %) had a concurrent diagnosis of osteomyelitis/cellulitis,
seven (4.4 %) expired during the initial hospital stay, two
(1.3 %) left against medical advice before undergoing echo-
cardiography, and one (0.6 %) was unable to proceed with
TEE due to restricted cervical motion.
Of the total 241 patients evaluated with echocardiography,
114 (47.3 %) were evaluated with TTE only, 56 (23.2 %) TEE
only, and 71 (29.5 %) TTE followed by TEE. Of the 241
patients evaluated with echocardiography studies, 234
(97.1 %) had their initial study done within 14 days after the
first positive blood culture result. Of the total 44 patients with
definite IE diagnosis, 24 (54.5 %) were evaluated with both
TTE and TEE, ten (22.7 %) were evaluated with TEE, and ten
(22.7 %) were evaluated with TTE alone.
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Prediction criteria for diagnosis of IE
The significant clinical predictors for diagnosis of IE are provid-
ed in Table 2. We considered less than one positive variable as
predicting low risk of IE. In total, 44 patients with documented
IE fulfilled at least one criterion (sensitivity 100 %, negative
predictive value 100 %, specificity 19.2 %, positive predictive
value 13.3 %). Of the 44 patients with documented IE, 34 ful-
filled at least two criteria (sensitivity 77.3 %, negative predictive
value 95.2 %, specificity 55.6 %, and positive predictive value
17.8 %). Among the 68 patients that fulfilled less than one of the
clinical predictors, 23 (33.8 %) were evaluated with TTE as the
first imaging study, five (7.4 %) with TEE alone, one (1.5 %)
underwent TEE followed by TTE, and 39 (57.5 %) did not have
any imaging done. Of the 39 patients not evaluated with echo-
cardiography, 33 (86.4 %) were categorized as rejected IE based
on the modified Duke criteria, four (10.3 %) expired during the
initial hospital stay, and in two cases (5.1 %), there was not
enough information in the chart review to determine the reason
for not evaluating with imaging.
AROCcurvewas obtained using our criteria (Fig. 1) andwas
compared to the criteria proposed by Kaasch et al. [1] (Fig. 2),
which included prolonged bacteremia, permanent intracardiac
device, prosthetic heart valve, pacemaker, cardioverter–
defibrillator, hemodialysis dependency, spinal infection, or
non-vertebral osteomyelitis. The area under the ROC curve for
our criteria was 0.710 (p<0.001), while the area under the ROC
curve for the simple criteria proposed by Kaasch et al. [1] was
0.537 (p=0.296). When comparing the ROC curve areas to a
reference area of 0.50 (the area that would be expected if no
predictive ability existed), our criteria had significantly better
ability to predict IE than Kaasch et al. [1] (P<0.001).
Association of the prediction criteria with mortality
When applying our criteria to predict mortality, we determined
that 19 (27.9 %) of the 68 patients with less than one of the
proposed criteria expired within 30 days of their diagnosis of
MRSA bacteremia, compared to 68 (20.6 %) of the 330 pa-
tients with one or more than one of the proposed criteria. We
found a sensitivity of 78.2 %, a specificity of 15.8 %, a pos-
itive predictive value of 20.6 % and a negative predictive
value of 72.1 % with a chi-square test p-value of 0.183, dem-
onstrating no statistically significant association of our pro-
posed prediction criteria with mortality. When applying the
criteria proposed by Kaasch et al. [1], we found that 19
(22.9 %) of the 83 patients with less than one of their proposed
criteria died within 30 days of their diagnosis, compared to 68
Table 1 Characteristics of 398






Age 58.6±17.1 44±12.4 59.7±17.3
Male 238 (59.8 %) 24 (54.5 %) 214 (60.5 %)
Nursing home resident 58 (14.6 %) 2 (4.5 %) 56 (15.8 %)
MRSA bacteremia characteristics
Community 105 (26.4 %) 22 (50 %) 83 (23.4 %)
Health care-associated 224 (56.3 %) 18 (40.9 %) 206 (58.2 %)
Hospital-acquired 69 (17.3 %) 4 (9.1 %) 65 (18.4 %)
Duration of MRSA bacteremia (median) 4.47 days 6.86 days 4.12 days
Presumed source of infection
Graft infection 10 (2.5 %) 1 (2.3 %) 9 (2.5 %)
Short term catheter 55 (13.8 %) 0 (0 %) 55 (15.5 %)
Implantable catheter 33 (8.3 %) 3 (6.8 %) 30 (8.5 %)
Skin/wound 132 (33.2 %) 9 (20.5 %) 123 (34.7 %)
Intra-abdominal 10 (2.5 %) 1 (2.3 %) 9 (2.5 %)
Respiratory 48 (12.1 %) 9 (20.5 %) 39 (11 %)
Para-spinal abscess 2 (0.5 %) 1 (2.3 %) 1 (0.3 %)
Urinary tract 36 (9 %) 0 (0 %) 36 (10.3 %)
Other 72 (18.1 %) 20 (45.5 %) 52 (14.7 %)
Comorbidities
Diabetes 161 (40.5 %) 13 (29.5 %) 148 (41.8 %)
Hemodialysis 90 (22.6 %) 4 (9.1 %) 86 (24.3 %)
HIV 20 (5 %) 5 (11.4 %) 15 (4.2 %)
Nursing home resident 58 (14.6 %) 2 (4.5 %) 56 (15.8 %)
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(27.5 %) of the 247 patients with one or more than one of the
proposed criteria. We found a sensitivity of 78.2%, specificity
of 20.6 %, positive predictive value of 21.6 % and a negative
predictive value of 77.1 with a chi-square test p-value of
0.798, also showing no statistically significant association of
their proposed prediction criteria with mortality.
Discussion
Our study accurately demonstrated that our simplified criteria
to risk stratify SAB patients effectively predicted patients with
MRSA bacteremia with very low risk of developing IE. Pre-
vious analysis by Kaasch et al. also demonstrated a high sen-
sitivity to diagnose IE by using simplified criteria [1], al-
though when the same criteria set was applied to our cohort
population, the area under the curve was smaller than our
proposed criteria that also included implantable catheter,
IVDA, cardio-structural abnormality and previous IE. These
four extra criteria added in our study represent important risk
factors in an inner-city population with high prevalence of
IVDU and implantable catheters.
In this retrospective analysis of patients with MRSA bac-
teremia, 44 (11%)were diagnosed with infective endocarditis.
Table 2 Clinical prediction criteria associated with increased risk of IE in patients with MRSA bacteremia
Prediction criterion All patients (n=398) Without IE (n=354) With IE (n=44) P-value Odds ratio Odds ratio
95 % confidence limits
Prolonged bacteremia 269 (67.5 %) 232 (65.5 %) 37 (84.1 %) 0.167 2.131 0.729 6.229
Intravenous drug use 85 (21.3 %) 53 (15 %) 32 (72.7 %) <0.001* 14.951 5.356 41.734
Implantable catheter 60 (15 %) 57 (16.1 %) 3 (6.8 %) 0.387 3.441 0.209 56.657
Intracardiac device 19 (4.7 %) 18 (5.1 %) 1 (2.3 %) 0.384 0.280 0.016 4.917
Prosthetic valve 19 (4.7 %) 7 (2 %) 6 (13.6 %) 0.002* 13.086 2.529 67.704
Hemodialysis 90 (22.6 %) 86 (24.3 %) 4 (9.1 %) 0.122 0.068 0.002 2.040
Osteomyelitis 52 (13 %) 46 (13 %) 6 (13.6 %) 0.067 0.287 0.076 1.089
Previous IE 19 (4.7 %%) 10 (2.8 %) 9 (20.5 %) 0.117 2.849 0.769 10.554
Cardio-structural abnormality 13 (3.2 %) 9 (2.5 %) 4 (9.1 %) 0.035* 6.095 1.132 32.833
*Statistically significant, P<0.05
Fig. 1 ROC curve for our
proposed clinical prediction
criteria set
Eur J Clin Microbiol Infect Dis (2016) 35:261–268 265
This prevalence of endocarditis in SAB is similar to previous
studies that have reported values between 5 and 17 % [1,
41–43,] and other studies have reported values up to 32 %
[24, 44, 45]. The 44 patients with IE had a 30-day overall
mortality of 25 % that is comparable to other reported studies
ranging from 13 to 31 % mortality [2, 41].
It is interesting to point out the lack of association of our
criteria with mortality. One of the possible explanations of this
result could be the fact that patients with more risk factors are
provided with advanced treatment protocols and early empir-
ical antimicrobial therapy. As has been previously reported,
inadequacy of empirical antimicrobial therapy in these pa-
tients is an important risk factor for mortality [46]. It has also
been reported that the APACHE II score has been associated
with mortality in patients with MRSA bacteremia [47]. Most
of the included variables in the APACHE II are not included in
our prediction criteria, as they mainly measure hemodynamic
values of the patients that are not necessary associated with IE.
Clinical implications
Although the current European Society of Cardiology, the
ACC/AHA guidelines and other recent studies recommend
performing routine echocardiography in all patients with
SAB [19, 23, 24], only 241 (60.5 %) of the cases in our study
complied with this recommendation, being one of the highest
reported [48]. Other studies have shown compliance results
ranging from 39.9 to 73 % [1, 24, 49, 50]. Even in a cohort
of patients with SAB presenting with intra-cardiac device and
higher risk of endocarditis, echocardiography was obtained in
only 77 % of cases [51]. An accurate definition of low proba-
bility of IE in patients with SAB is still lacking, and is neces-
sary to provide better guidance of how to use echocardiogra-
phy. Our criteria could potentially be used as a tool to identify
patients with MRSA bacteremia at low risk of endocarditis, in
order to guide the mode of echocardiography. In patients with
one or more of the proposed criteria, the risk of developing IE
is higher, and TEE should be considered in their evaluation. In
patients with less than one of the proposed criteria, their risk of
IE is low and TEE might not be needed for their evaluation. In
our cohort, TEE results did not change or add to the manage-
ment in any of the low-risk patients. It could be argued that in
patients with community-acquiredMRSA and very low risk of
IE, the real duration of bacteremia is unknown, and as such,
considering ordering a TTE should not be discouraged. While
patients with less than one of the proposed criteria are at low
risk of IE, they are still at very high risk of poor outcomes.
Absence of IE does not imply absence of complicated disease
in patients with MRSA bacteremia. It will be important to
validate these criteria prospectively and follow the subjects in
the long term in order to include missed cases of endocarditis.
Limitations
As our analysis was retrospective, there are several inherent
limitations in this type of study design. Adequately identifying
missed cases of IE was not possible, as there was no follow-up
Fig. 2 ROC curve for clinical
prediction criteria set proposed
by Kaasch et al. [1]
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arranged. With the goal of capturing patients with missed IE,
we performed a second chart review of medical records that
corresponded to 6 months after MRSA was initially diag-
nosed. Even though we did not find any information
supporting missed IE in patients with none of our prediction
criteria, the review was still limited by the fact that we did not
capture the actual cause of death, so some patients could have
followed up at another institution or died before having a
complete evaluation for IE. It is important to mention that
source control was at discretion of the clinicians caring for
the patient; as a retrospective chart review, this information
was not consistently available. Additionally, not all patients in
our cohort underwent TTE or TEE evaluation, limiting the
diagnostic power of Duke criteria due to the fact that IE is
not easily recognized by physical examination. This also lim-
ited our ability to classify patients as rejected IE. We per-
formed a second chart review of all 116 patients that were
classified as rejected IE, with the goal of identifying the rea-
sons why no imaging was done. All of these 116 patients
either had a firm alternate diagnosis for the manifestations of
IE, the manifestations of infection resolved within 4 days, or
they did not meet criteria for possible IE. The use of Duke
criteria in these patients continues to be limited due to the fact
that we did not have echocardiography evaluations or patho-
logic evidence at surgery or autopsy from any of them. As
such, the actual number of IE cases may have been
underestimated.
Conclusion
In conclusion, patients with MRSA bacteremia and at least
one of our proposed clinical criteria have an inherently higher
risk of IE, and TEE should be considered for their evaluation.
Patients with less than one of our proposed criteria have very
low risk of developing IE and might not need TEE for their
evaluation. It is important to mention that in patients with less
than one of our proposed criteria, physicians should not be
discouraged from performing TTE in their evaluation, as such
patients are still considered at risk of developing IE.
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